The Role of Ghost Ileostomy in Laparoscopic Rectal Resection (GILRR)

November 20, 2016 updated by: Francesco Saverio Mari, University of Roma La Sapienza
To evaluate if the Ghost Ileostomy is really advantageous in laparoscopy we conducted a prospective randomized controlled study comparing 2 groups of patients undergoing anterior resection of the rectum laparoscopically. In the first group of patients at the end of the procedure was always performed a Ghost Ileostomy while in the second group no protective stoma was built at the end of the intervention.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

107

Phase

  • Phase 3

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Surgical Indication for Laparoscopic Anterior Rectal Resection
  • Medium risk of anastomotic leakage

Exclusion Criteria:

  • High risk of anastomotic leakage
  • Lower risk of anastomotic leakage
  • Advanced neoplasia (T4)
  • Indication for inter-sphincteric resection hydro-pneumatic test of the anastomosis tightness showed positive for air leak
  • Surgical procedure intraoperatively modified from the standard laparoscopic anterior rectal resection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ghost Ileostomy
The patients were subjected to laparoscopic anterior rectal resection with performance of ghost ileostomy
At the end of Laparoscopic Anterior Rectal Resection, once the colorectal anastomosis was performed, the terminal ileum was identified and a window in the mesentery was created to pass a rubber tube (we usually use an urinary catheter) around the intestinal loop. The tube was subsequently exteriorized trough the trocar incision in the right flank.
Other Names:
  • Virtual Ileostomy
Placebo Comparator: No protective stoma
The patients were subjected to laparoscopic anterior rectal resection without simultaneous construction of any protective stoma.
At the end of Laparoscopic Anterior Rectal Resection, once the colorectal anastomosis was performed, the terminal ileum was identified and a window in the mesentery was created to pass a rubber tube (we usually use an urinary catheter) around the intestinal loop. The tube was subsequently exteriorized trough the trocar incision in the right flank.
Other Names:
  • Virtual Ileostomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Presence of Clinical Evident Anastomotic Leak
Time Frame: 15 days
15 days

Secondary Outcome Measures

Outcome Measure
Time Frame
Postoperative complication
Time Frame: 15 days
15 days
Ghost Ileostomy complications
Time Frame: 15 days
15 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2007

Primary Completion (Actual)

January 1, 2013

Study Completion (Actual)

January 1, 2013

Study Registration Dates

First Submitted

May 21, 2013

First Submitted That Met QC Criteria

May 21, 2013

First Posted (Estimate)

May 23, 2013

Study Record Updates

Last Update Posted (Estimate)

November 22, 2016

Last Update Submitted That Met QC Criteria

November 20, 2016

Last Verified

November 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • DS-008

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colo-rectal Anastomosis Dehiscence

Clinical Trials on Ghost Ileostomy

3
Subscribe